Unmet Needs in Ankylosing Spondylitis Patients Receiving Tumour Necrosis Factor Inhibitor Therapy; Results From a Large Multinational Real-World Study

BMC Rheumatology - United Kingdom
doi 10.1186/s41927-020-0118-z
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Response to Tumor Necrosis Factor Inhibition in Male and Female Patients With Ankylosing Spondylitis: Data From a Swiss Cohort

Journal of Rheumatology
RheumatologyAllergyImmunology
2018English

Withdrawal of Infliximab Therapy in Ankylosing Spondylitis in Persistent Clinical Remission, Results From the REMINEA Study

Arthritis Research & Therapy
2019English

Tumour Necrosis Factor-Α Inhibitors for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: A Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2016English

Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Symptomatic Therapy for Ankylosing Spondylitis

Modern Rheumatology Journal
2012English

Assessing Patients’ Acceptance of Their Medication to Reveal Unmet Needs: Results From a Large Multi-Diseases Study Using a Patient Online Community

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2018English

P082 Circulating Mir-145 as a Marker of Therapeutic Response in Patients With Ankylosing Spondylitis Receiving Anti-TNF Therapy

2018English

Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy